A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

NCT03138512 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1641

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

BIOLOGICAL: nivolumab
BIOLOGICAL: ipilimumab
DRUG: nivolumab placebo
DRUG: ipilimumab placebo

Sponsor

Bristol-Myers Squibb